70 related articles for article (PubMed ID: 734836)
1. [Treatment of central tapeto-retinal abiotrophies with FAD (flavin-adenine dinucleotide)].
Katsnel'son LA; Trutneva KV; Osadchikh VG; Iakovlev AA; Miliavskaia TI
Vestn Oftalmol; 1978; (6):63-7. PubMed ID: 734836
[No Abstract] [Full Text] [Related]
2. [Treatment results using the preparation ENKAD in patients with peripheral tapetoretinal abiotrophy].
Katsnel'son LA; Maslova-Khoroshilova IP; Eliseeva RF; Dnestrova GI
Vestn Oftalmol; 1988; 104(6):54-61. PubMed ID: 3242209
[No Abstract] [Full Text] [Related]
3. [Clinical trial using RNA preparations for treatment of tapeto-retinal dystrophies].
Shershevskaia SF; Levina FG
Vestn Akad Med Nauk SSSR; 1978; (10):40-4. PubMed ID: 706719
[No Abstract] [Full Text] [Related]
4. [Clinical symptoms of retinal dystrophies in mitochondriopathies].
Hammerstein W; Bosche J
Fortschr Ophthalmol; 1988; 85(5):505-7. PubMed ID: 3224922
[No Abstract] [Full Text] [Related]
5. Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies.
Beutler E
J Clin Invest; 1969 Oct; 48(10):1957-66. PubMed ID: 5822598
[TBL] [Abstract][Full Text] [Related]
6. Retinal pigment hypertrophy and chorioretinal dystrophy.
De Laey JJ; Leys A; Van Hyfte R
Bull Soc Belge Ophtalmol; 1987; 223 Pt 2():67-73. PubMed ID: 3502795
[No Abstract] [Full Text] [Related]
7. Evaluation of phenotypic similarities between Stargardt flavimaculatus and retinal pigment epithelial pattern dystrophies.
Aaberg TM; Han DP
Trans Am Ophthalmol Soc; 1987; 85():101-19. PubMed ID: 3447330
[No Abstract] [Full Text] [Related]
8. Additive therapeutic effects of the liver extract preparation mixture adelavin-9 on interferon-beta treatment for chronic hepatitis C.
Ebinuma H; Saito H; Tada S; Masuda T; Kamiya T; Nishida J; Yoshioka M; Ishii H;
Hepatogastroenterology; 2004; 51(58):1109-14. PubMed ID: 15239256
[TBL] [Abstract][Full Text] [Related]
9. Retinal degeneration is delayed by tissue factor pathway inhibitor-2 in RCS rats and a sodium-iodate-induced model in rabbits.
Obata R; Yanagi Y; Tamaki Y; Hozumi K; Mutoh M; Tanaka Y
Eye (Lond); 2005 Apr; 19(4):464-8. PubMed ID: 15184935
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of tapetoretinal dystrophy with an adenosine triphosphoric acid preparation].
Mikhaĭlovskaia IE; Salganik RI
Oftalmol Zh; 1982; 37(3):157-9. PubMed ID: 7133586
[No Abstract] [Full Text] [Related]
11. [Clinical effects of flavitan in diseases of oral mucosa and serum vitamin B2 levels].
Zaimitsu S; Sakeizumi K; Asanami S; Sato H; Asanami Y
Shikai Tenbo; 1978; 52(6):1105-11. PubMed ID: 295931
[No Abstract] [Full Text] [Related]
12. [Interaction of muscle glycogen phosphorylase B with flavin-adenine dinucleotide and its analogs].
Klinov SV; Chebotareva NA; Kurganov BI; Litvak ZhI; Zhilina TA
Bioorg Khim; 1985 Feb; 11(2):196-204. PubMed ID: 3922380
[TBL] [Abstract][Full Text] [Related]
13. [Effect of the combined use of flavin coenzyme preparations and pyridoxine on the body vitamin balance in animals].
Stroev EA; Kazakova NT
Farmakol Toksikol; 1980; 43(5):601-3. PubMed ID: 7449991
[TBL] [Abstract][Full Text] [Related]
14. Analysis of flavins in ocular tissues of the rabbit.
Batey DW; Eckhert CD
Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):1981-5. PubMed ID: 2055692
[TBL] [Abstract][Full Text] [Related]
15. Episcleritis associated with pigmentary retinal degeneration in an HTLV-I carrier.
Nomura E; Kimura T; Yabuki K; Kurita M; Goto K; Ohno S
Tokai J Exp Clin Med; 1998 Oct; 23(4):183-5. PubMed ID: 10359508
[TBL] [Abstract][Full Text] [Related]
16. [ETO in the treatment of degenerative retinal changes caused by high myopia].
Kozielec J; Remlein-Mozolewska G
Klin Oczna; 1976; 46(12):1409-14. PubMed ID: 1011671
[No Abstract] [Full Text] [Related]
17. [Bio-electric tests in tapeto-retinal peripheral degeneration].
François J; De Rouck A
Bull Soc Belge Ophtalmol; 1974; 166(2):504-16. PubMed ID: 4433950
[No Abstract] [Full Text] [Related]
18. Hemodynamic responses elicited by systemic injections of flavin adenine dinucleotide in anesthetized rats.
Hashmi-Hill MP; Graves JE; Sandock K; Bates JN; Robertson TP; Lewis SJ
J Cardiovasc Pharmacol; 2007 Jul; 50(1):94-102. PubMed ID: 17666921
[TBL] [Abstract][Full Text] [Related]
19. [Clinical use of "Flavitan" in some mucosal diseases of the mouth].
Matsuda N; Ihara K
Shikai Tenbo; 1979; 53(3):511-3. PubMed ID: 295972
[No Abstract] [Full Text] [Related]
20. Normal riboflavin status in malaria patients in Gabon.
Traunmüller F; Ramharter M; Lagler H; Thalhammer F; Kremsner PG; Graninger W; Winkler S
Am J Trop Med Hyg; 2003 Feb; 68(2):182-5. PubMed ID: 12641409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
